Besides, although mature TLS (namely SFL‐TLS, with CD23+ GC cells) fail to exert significant differences in PFS (p = 0.111), while predicted remarkably elevated OS (p = 0.020, HR = 0.370) than ccRCC patients with immature TLS (Figure 6G). Here, FCER2 is linked to nonpapillary renal cell carcinoma.